Literature DB >> 17078204

Metaplasia--a transdifferentiation process that facilitates cancer development: the model of gastric intestinal metaplasia.

Patrícia Mesquita1, Almeida Raquel, Lunet Nuno, Celso A Reis, Luís Filipe Santos Silva, Jacinta Serpa, Isabelle Van Seuningen, Henrique Barros, Leonor David.   

Abstract

Metaplasia, in general, and intestinal metaplasia, in particular, are transdifferentiation processes triggered by environmental aggressions. The heterogeneity of different morphologic variants of metaplasia and distinction from close morphologic entities--heterotopia and hamartoma--is reviewed. Recent data on the characterization of the molecular and epidemiological data involved in the development and progression of lesions of gastric intestinal metaplasia are discussed. A redefinition of intestinal metaplasia is proposed.

Entities:  

Mesh：

Year:  2006        PMID： 17078204     DOI： 10.1615/critrevoncog.v12.i1-2.20

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN： 0893-9675


  10 in total

1.  Changing the natural history of metachronous gastric cancer after H. pylori eradication.

Authors:  David Y Graham; Satoko Matsueda; Akiko Shiotani
Journal:  Jpn J Helicobacter Res       Date:  2015

Review 2.  Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.

Authors:  David Y Graham
Journal:  Gastroenterology       Date:  2015-02-02       Impact factor: 22.682

3.  Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma.

Authors:  Joana Gomes; Nuno T Marcos; Nora Berois; Eduardo Osinaga; Ana Magalhães; João Pinto-de-Sousa; Raquel Almeida; Fátima Gärtner; Celso A Reis
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

Review 4.  New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer.

Authors:  Lin-Hai Yan; Wei-Yuan Wei; Yu-Bo Xie; Qiang Xiao
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

5.  Juvenile polyps have gastric differentiation with MUC5AC expression and downregulation of CDX2 and SMAD4.

Authors:  Rita Barros; Nuno Mendes; James R Howe; Celso A Reis; Carme de Bolos; Fátima Carneiro; Leonor David; Raquel Almeida
Journal:  Histochem Cell Biol       Date:  2009-03-06       Impact factor: 4.304

Review 6.  Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?

Authors:  Yoku Hayakawa; Nilay Sethi; Antonia R Sepulveda; Adam J Bass; Timothy C Wang
Journal:  Nat Rev Cancer       Date:  2016-04-26       Impact factor: 60.716

7.  Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.

Authors:  Osmel Companioni; José Miguel Sanz-Anquela; María Luisa Pardo; Eulàlia Puigdecanet; Lara Nonell; Nadia García; Verónica Parra Blanco; Consuelo López; Victoria Andreu; Miriam Cuatrecasas; Maddi Garmendia; Javier P Gisbert; Carlos A Gonzalez; Núria Sala
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

8.  ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.

Authors:  Eun-Hye Seo; Hee-Jin Kim; Jong-Hwan Kim; Byungho Lim; Jong-Lyul Park; Seon-Young Kim; Sang-Il Lee; Hyun-Yong Jeong; Kyu-Sang Song; Yong-Sung Kim
Journal:  Int J Cancer       Date:  2020-03-20       Impact factor: 7.396

9.  STK31 upregulation is associated with chromatin remodeling in gastric cancer and induction of tumorigenicity in a xenograft mouse model.

Authors:  Dong Hyuck Bae; Hee-Jin Kim; Byoung-Ha Yoon; Jong-Lyul Park; Mirang Kim; Seon-Kyu Kim; Seon-Young Kim; Sang-Il Lee; Kyu-Sang Song; Yong Sung Kim
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

10.  Casein kinase 2 interacting protein 1 positively regulates caudal-related homeobox 1 in intestinal-type gastric cancer.

Authors:  Liang Ma; Ying Cao; Jian-Jun Hu; Ming-Liang Chu
Journal:  Chin Med J (Engl)       Date:  2020-01-20       Impact factor: 2.628
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.